We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a quasi-experimental study to evaluate your digital health product.
How to use a before-and-after study to evaluate your digital health product.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
How to use a randomised controlled trial to evaluate your digital health product.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
An analysis of this alternative method of data collection to overcome non-disclosure.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).